PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1954605
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1954605
The global clinical perinatal software market was valued at USD 375.73 million in 2025 and is projected to grow from USD 406.2 million in 2026 to USD 989.3 million by 2034, registering a strong CAGR of 11.77% during the forecast period. North America dominated the market in 2025 with a 41.32% share, driven by high digital health adoption and rising maternal health concerns.
Market Overview
Clinical perinatal software refers to specialized digital platforms used in maternal-fetal and neonatal care. These systems support healthcare providers in managing pregnancy, labor & delivery, and newborn care through real-time monitoring, clinical decision support, and integration with electronic health records (EHRs). The growing emphasis on reducing birth-related risks, improving maternal outcomes, and digitizing hospital systems is significantly contributing to market growth.
Leading players such as General Electric Company, Koninklijke Philips N.V., PeriGen, Inc., and Clinical Computer Systems, Inc. are strengthening their positions through innovative product launches and global expansion strategies.
Market Drivers
Rising Maternal & Neonatal Health Burden
The increasing global burden of maternal and neonatal complications is a primary driver of market growth. Conditions such as preeclampsia, hemorrhage, obstructed labor, intrapartum hypoxia, and prematurity-related complications require continuous monitoring and early intervention.
According to a WHO report published in April 2025, approximately 260,000 women died from pregnancy and childbirth-related causes in 2023, with nearly 90% occurring in low- and middle-income countries. Clinical perinatal software plays a crucial role in reducing mortality by enabling early detection, real-time fetal monitoring, and improved clinical decision-making.
Market Restraints
Limited adoption in emerging economies restricts overall market expansion. Infrastructure gaps, high software implementation costs, lack of trained personnel, and reliance on donor-funded programs hinder widespread deployment. For instance, Zambia's Electronic Perinatal Record System (ZEPRS) was implemented with support from global funding organizations, highlighting dependency on external financial assistance.
High upfront costs for IT infrastructure and integration further slow adoption among smaller hospitals and specialty clinics. In 2024, the Department of Health and Social Care and NHS England invested USD 225 million annually to enhance maternity and neonatal care, demonstrating the significant financial commitment required.
Market Opportunities
Integration with Telehealth & Remote Monitoring
The growing shift toward hybrid prenatal care models combining digital consultations with in-person visits presents a lucrative opportunity. Telehealth adoption surged during the COVID-19 pandemic. A study published by NCBI in June 2023 revealed that 17.3% of participants had telehealth prenatal visits in November 2020, compared to just 1% before 2020.
Cloud-based SaaS platforms, mobile apps, and connected monitoring devices are expanding access to maternal care while creating subscription-based revenue models for providers.
Market Trends
Shift Toward Cloud & SaaS Deployment
Hospitals are increasingly migrating toward cloud-based systems due to cost efficiency, scalability, and remote accessibility. Although on-premise systems currently dominate, cloud-based solutions are gaining traction, especially in high-income countries.
By Type
The integrated segment led the market with a 69.18% share in 2026, driven by demand for seamless data integration and improved workflow efficiency. Integrated systems reduce data silos and enhance clinical decision-making.
By Deployment
The on-premise segment accounted for 73.25% share in 2026, as hospitals prioritize data security and regulatory compliance. However, the cloud-based segment is projected to grow at a CAGR of 13.93% through 2034.
By Application
The fetal monitoring segment dominated with 37.4% share in 2025 and 36.74% in 2026, due to its clinical importance in detecting abnormal heart rate patterns and preventing neonatal complications. The maternal health management segment is projected to grow at 12.52% CAGR during the forecast period.
By End-User
Hospitals & clinics held 69.7% share in 2025 and 69.49% in 2026, as these settings manage high-risk pregnancies and neonatal intensive care cases. Specialty clinics are expected to grow at a CAGR of 12.44% through 2034.
In 2025, North America generated USD 155.25 million, increasing to USD 168.17 million in 2026, maintaining regional leadership. The U.S. market alone is estimated at USD 154.42 million in 2026, supported by rising maternal mortality rates (22.3 deaths per 100,000 live births in 2022).
Europe is projected to reach USD 92.8 million in 2025, growing at a CAGR of 9.96%. Germany is expected to reach USD 23.94 million in 2026, while the U.K. and France show steady growth.
Asia Pacific is valued at USD 85.0 million in 2025, with China and India reaching USD 23.76 million and USD 18.38 million in 2026, respectively.
Latin America recorded USD 24.4 million in 2025, while GCC in the Middle East & Africa reached USD 7.6 million in 2025.
Competitive Landscape
The market is moderately fragmented with dominant players including:
Recent developments include OBIX's partnership with Dubai Health (January 2025) and BrightHeart's FDA clearance for AI fetal heart ultrasound software (November 2024).
Conclusion
The global clinical perinatal software market is poised for strong expansion, growing from USD 375.73 million in 2025 to USD 989.3 million by 2034. Rising maternal health challenges, increasing digital health adoption, and growing integration of telehealth and AI-driven monitoring systems are key growth drivers. While high implementation costs and limited adoption in emerging economies present challenges, expanding cloud-based solutions and government investments are expected to sustain long-term growth across global healthcare systems.
Segmentation By Type
By Deployment
By Application
By End User
By Geography